Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes
BackgroundThirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition. However, clinical guidelines do not recommend cannabis for treatment of chronic non-ca...
Gespeichert in:
| Veröffentlicht in: | Implementation science : IS 2021-01, Vol.16 (1), p.2-13, Article 2 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 13 |
|---|---|
| container_issue | 1 |
| container_start_page | 2 |
| container_title | Implementation science : IS |
| container_volume | 16 |
| creator | McGinty, Emma E. Tormohlen, Kayla N. Barry, Colleen L. Bicket, Mark C. Rutkow, Lainie Stuart, Elizabeth A. |
| description | BackgroundThirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition. However, clinical guidelines do not recommend cannabis for treatment of chronic non-cancer pain due to limited and mixed evidence of effectiveness. How state medical cannabis laws affect delivery of evidence-based treatment for chronic non-cancer pain is unclear. These laws could lead to substitution of cannabis in place of clinical guideline-discordant opioid prescribing, reducing risk of opioid use disorder and overdose. Conversely, state medical cannabis laws could lead to substitution of cannabis in place of guideline-concordant treatments such as topical analgesics or physical therapy. This protocol describes a mixed-methods study examining the implementation and effects of state medical cannabis laws on treatment of chronic non-cancer pain. A key contribution of the study is the examination of how variation in state medical cannabis laws' policy implementation rules affects receipt of chronic non-cancer pain treatments.MethodsThe study uses a concurrent-embedded design. The primary quantitative component of the study employs a difference-in-differences design using a policy trial emulation approach. Quantitative analyses will evaluate state medical cannabis laws' effects on treatment for chronic non-cancer pain as well as on receipt of treatment for opioid use disorder, opioid overdose, cannabis use disorder, and cannabis poisoning among people with chronic non-cancer pain. Secondary qualitative and survey methods will be used to characterize implementation of state medical cannabis laws through interviews with state leaders and representative surveys of physicians who treat, and patients who experience, chronic non-cancer pain in states with medical cannabis laws.DiscussionThis study will examine the effects of medical cannabis laws on patients' receipt of guideline-concordant non-opioid, non-cannabis treatments for chronic non-cancer pain and generate new evidence on the effects of state medical cannabis laws on adverse opioid outcomes. Results will inform the dynamic policy environment in which numerous states consider, enact, and/or amend medical cannabis laws each year. |
| doi_str_mv | 10.1186/s13012-020-01071-2 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2478689623</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A650597091</galeid><doaj_id>oai_doaj_org_article_73457d08ba1b4152b06b6a1a7f6c69f2</doaj_id><sourcerecordid>A650597091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-c77ceaa3b2689ca584c85b9cf0c1c7d56c6856bd960380c61fdd8ce46429558f3</originalsourceid><addsrcrecordid>eNqNks1u1DAUhSMEoqXwAiyQJZYoxc6P7bBAqkb8VKoEEnRtOdf2jEeJPdhOh74Mz4rTlKEjsUBZxLn5zomPc4riJcHnhHD6NpIak6rEFS4xwYyU1aPilLCGl22H-eMH65PiWYxbjJu2ofXT4qSuG1Lnh9Pi19fgkwc_vEOj_alVOeq08SqimCZ1i7xBG79HdtwNetQuyWS9m6fX3zIhk0ajVhbkgEA6J3sb0SD3EUljNKSIUtAyzcJZA5vgnQXkvCszDjqgnbQOSaeQVDc6RI38znqrkJ8S-FHH58UTI4eoX9zfz4rrjx--rz6XV18-Xa4urkpoaZ1KYAy0lHVfUd6BbHkDvO07MBgIMNVSoLylveoorjkGSoxSHHRDm6prW27qs-Jy8VVebsUu2FGGW-GlFXcDH9ZChmRh0ILlg2MK816SviFt1WPaU0kkM_krnamy1_vFazf1-XQgpw9yODI9fuPsRqz9jWCMdw3m2eD1vUHwPyYdk9j6KbicX1QN4zkireq_1FrmXVlnfDaD0UYQF7TFbcdwRzJ1_g8qX0qPFrzTxub5kaBaBBB8jEGbw8YJFnPtxFI7kWsn7mon5sivHkY-SP70LANvFmCve28iWJ1__wHDGFPMK8ZoXuHZjv8_vbJLK1d-cqn-DadT9fE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2478689623</pqid></control><display><type>article</type><title>Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>McGinty, Emma E. ; Tormohlen, Kayla N. ; Barry, Colleen L. ; Bicket, Mark C. ; Rutkow, Lainie ; Stuart, Elizabeth A.</creator><creatorcontrib>McGinty, Emma E. ; Tormohlen, Kayla N. ; Barry, Colleen L. ; Bicket, Mark C. ; Rutkow, Lainie ; Stuart, Elizabeth A.</creatorcontrib><description>BackgroundThirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition. However, clinical guidelines do not recommend cannabis for treatment of chronic non-cancer pain due to limited and mixed evidence of effectiveness. How state medical cannabis laws affect delivery of evidence-based treatment for chronic non-cancer pain is unclear. These laws could lead to substitution of cannabis in place of clinical guideline-discordant opioid prescribing, reducing risk of opioid use disorder and overdose. Conversely, state medical cannabis laws could lead to substitution of cannabis in place of guideline-concordant treatments such as topical analgesics or physical therapy. This protocol describes a mixed-methods study examining the implementation and effects of state medical cannabis laws on treatment of chronic non-cancer pain. A key contribution of the study is the examination of how variation in state medical cannabis laws' policy implementation rules affects receipt of chronic non-cancer pain treatments.MethodsThe study uses a concurrent-embedded design. The primary quantitative component of the study employs a difference-in-differences design using a policy trial emulation approach. Quantitative analyses will evaluate state medical cannabis laws' effects on treatment for chronic non-cancer pain as well as on receipt of treatment for opioid use disorder, opioid overdose, cannabis use disorder, and cannabis poisoning among people with chronic non-cancer pain. Secondary qualitative and survey methods will be used to characterize implementation of state medical cannabis laws through interviews with state leaders and representative surveys of physicians who treat, and patients who experience, chronic non-cancer pain in states with medical cannabis laws.DiscussionThis study will examine the effects of medical cannabis laws on patients' receipt of guideline-concordant non-opioid, non-cannabis treatments for chronic non-cancer pain and generate new evidence on the effects of state medical cannabis laws on adverse opioid outcomes. Results will inform the dynamic policy environment in which numerous states consider, enact, and/or amend medical cannabis laws each year.</description><identifier>ISSN: 1748-5908</identifier><identifier>EISSN: 1748-5908</identifier><identifier>DOI: 10.1186/s13012-020-01071-2</identifier><identifier>PMID: 33413454</identifier><language>eng</language><publisher>LONDON: Springer Nature</publisher><subject>Analgesics, Opioid ; Arthritis ; Cancer therapies ; Cannabis ; Care and treatment ; Chronic pain ; Chronic Pain - drug therapy ; Data collection ; Econometrics ; Health Care Sciences & Services ; Health Policy & Services ; Humans ; Law ; Laws, regulations and rules ; Life Sciences & Biomedicine ; Medical marijuana ; Medical Marijuana - therapeutic use ; Mixed methods research ; Mixed-methods ; Narcotics ; Pain ; Pain management ; Patients ; Poisoning ; Policy implementation ; Population ; Practice Patterns, Physicians ; Public policy ; Science & Technology ; Study Protocol</subject><ispartof>Implementation science : IS, 2021-01, Vol.16 (1), p.2-13, Article 2</ispartof><rights>COPYRIGHT 2021 BioMed Central Ltd.</rights><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>4</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000608277600002</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c563t-c77ceaa3b2689ca584c85b9cf0c1c7d56c6856bd960380c61fdd8ce46429558f3</citedby><cites>FETCH-LOGICAL-c563t-c77ceaa3b2689ca584c85b9cf0c1c7d56c6856bd960380c61fdd8ce46429558f3</cites><orcidid>0000-0002-9042-8611 ; 0000-0001-9406-5953</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789408/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789408/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27928,27929,53795,53797</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33413454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McGinty, Emma E.</creatorcontrib><creatorcontrib>Tormohlen, Kayla N.</creatorcontrib><creatorcontrib>Barry, Colleen L.</creatorcontrib><creatorcontrib>Bicket, Mark C.</creatorcontrib><creatorcontrib>Rutkow, Lainie</creatorcontrib><creatorcontrib>Stuart, Elizabeth A.</creatorcontrib><title>Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes</title><title>Implementation science : IS</title><addtitle>IMPLEMENT SCI</addtitle><addtitle>Implement Sci</addtitle><description>BackgroundThirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition. However, clinical guidelines do not recommend cannabis for treatment of chronic non-cancer pain due to limited and mixed evidence of effectiveness. How state medical cannabis laws affect delivery of evidence-based treatment for chronic non-cancer pain is unclear. These laws could lead to substitution of cannabis in place of clinical guideline-discordant opioid prescribing, reducing risk of opioid use disorder and overdose. Conversely, state medical cannabis laws could lead to substitution of cannabis in place of guideline-concordant treatments such as topical analgesics or physical therapy. This protocol describes a mixed-methods study examining the implementation and effects of state medical cannabis laws on treatment of chronic non-cancer pain. A key contribution of the study is the examination of how variation in state medical cannabis laws' policy implementation rules affects receipt of chronic non-cancer pain treatments.MethodsThe study uses a concurrent-embedded design. The primary quantitative component of the study employs a difference-in-differences design using a policy trial emulation approach. Quantitative analyses will evaluate state medical cannabis laws' effects on treatment for chronic non-cancer pain as well as on receipt of treatment for opioid use disorder, opioid overdose, cannabis use disorder, and cannabis poisoning among people with chronic non-cancer pain. Secondary qualitative and survey methods will be used to characterize implementation of state medical cannabis laws through interviews with state leaders and representative surveys of physicians who treat, and patients who experience, chronic non-cancer pain in states with medical cannabis laws.DiscussionThis study will examine the effects of medical cannabis laws on patients' receipt of guideline-concordant non-opioid, non-cannabis treatments for chronic non-cancer pain and generate new evidence on the effects of state medical cannabis laws on adverse opioid outcomes. Results will inform the dynamic policy environment in which numerous states consider, enact, and/or amend medical cannabis laws each year.</description><subject>Analgesics, Opioid</subject><subject>Arthritis</subject><subject>Cancer therapies</subject><subject>Cannabis</subject><subject>Care and treatment</subject><subject>Chronic pain</subject><subject>Chronic Pain - drug therapy</subject><subject>Data collection</subject><subject>Econometrics</subject><subject>Health Care Sciences & Services</subject><subject>Health Policy & Services</subject><subject>Humans</subject><subject>Law</subject><subject>Laws, regulations and rules</subject><subject>Life Sciences & Biomedicine</subject><subject>Medical marijuana</subject><subject>Medical Marijuana - therapeutic use</subject><subject>Mixed methods research</subject><subject>Mixed-methods</subject><subject>Narcotics</subject><subject>Pain</subject><subject>Pain management</subject><subject>Patients</subject><subject>Poisoning</subject><subject>Policy implementation</subject><subject>Population</subject><subject>Practice Patterns, Physicians</subject><subject>Public policy</subject><subject>Science & Technology</subject><subject>Study Protocol</subject><issn>1748-5908</issn><issn>1748-5908</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>GIZIO</sourceid><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNqNks1u1DAUhSMEoqXwAiyQJZYoxc6P7bBAqkb8VKoEEnRtOdf2jEeJPdhOh74Mz4rTlKEjsUBZxLn5zomPc4riJcHnhHD6NpIak6rEFS4xwYyU1aPilLCGl22H-eMH65PiWYxbjJu2ofXT4qSuG1Lnh9Pi19fgkwc_vEOj_alVOeq08SqimCZ1i7xBG79HdtwNetQuyWS9m6fX3zIhk0ajVhbkgEA6J3sb0SD3EUljNKSIUtAyzcJZA5vgnQXkvCszDjqgnbQOSaeQVDc6RI38znqrkJ8S-FHH58UTI4eoX9zfz4rrjx--rz6XV18-Xa4urkpoaZ1KYAy0lHVfUd6BbHkDvO07MBgIMNVSoLylveoorjkGSoxSHHRDm6prW27qs-Jy8VVebsUu2FGGW-GlFXcDH9ZChmRh0ILlg2MK816SviFt1WPaU0kkM_krnamy1_vFazf1-XQgpw9yODI9fuPsRqz9jWCMdw3m2eD1vUHwPyYdk9j6KbicX1QN4zkireq_1FrmXVlnfDaD0UYQF7TFbcdwRzJ1_g8qX0qPFrzTxub5kaBaBBB8jEGbw8YJFnPtxFI7kWsn7mon5sivHkY-SP70LANvFmCve28iWJ1__wHDGFPMK8ZoXuHZjv8_vbJLK1d-cqn-DadT9fE</recordid><startdate>20210107</startdate><enddate>20210107</enddate><creator>McGinty, Emma E.</creator><creator>Tormohlen, Kayla N.</creator><creator>Barry, Colleen L.</creator><creator>Bicket, Mark C.</creator><creator>Rutkow, Lainie</creator><creator>Stuart, Elizabeth A.</creator><general>Springer Nature</general><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>17B</scope><scope>BLEPL</scope><scope>DTL</scope><scope>DVR</scope><scope>EGQ</scope><scope>GIZIO</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9042-8611</orcidid><orcidid>https://orcid.org/0000-0001-9406-5953</orcidid></search><sort><creationdate>20210107</creationdate><title>Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes</title><author>McGinty, Emma E. ; Tormohlen, Kayla N. ; Barry, Colleen L. ; Bicket, Mark C. ; Rutkow, Lainie ; Stuart, Elizabeth A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-c77ceaa3b2689ca584c85b9cf0c1c7d56c6856bd960380c61fdd8ce46429558f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analgesics, Opioid</topic><topic>Arthritis</topic><topic>Cancer therapies</topic><topic>Cannabis</topic><topic>Care and treatment</topic><topic>Chronic pain</topic><topic>Chronic Pain - drug therapy</topic><topic>Data collection</topic><topic>Econometrics</topic><topic>Health Care Sciences & Services</topic><topic>Health Policy & Services</topic><topic>Humans</topic><topic>Law</topic><topic>Laws, regulations and rules</topic><topic>Life Sciences & Biomedicine</topic><topic>Medical marijuana</topic><topic>Medical Marijuana - therapeutic use</topic><topic>Mixed methods research</topic><topic>Mixed-methods</topic><topic>Narcotics</topic><topic>Pain</topic><topic>Pain management</topic><topic>Patients</topic><topic>Poisoning</topic><topic>Policy implementation</topic><topic>Population</topic><topic>Practice Patterns, Physicians</topic><topic>Public policy</topic><topic>Science & Technology</topic><topic>Study Protocol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McGinty, Emma E.</creatorcontrib><creatorcontrib>Tormohlen, Kayla N.</creatorcontrib><creatorcontrib>Barry, Colleen L.</creatorcontrib><creatorcontrib>Bicket, Mark C.</creatorcontrib><creatorcontrib>Rutkow, Lainie</creatorcontrib><creatorcontrib>Stuart, Elizabeth A.</creatorcontrib><collection>Web of Knowledge</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Social Sciences Citation Index</collection><collection>Web of Science Primary (SCIE, SSCI & AHCI)</collection><collection>Web of Science - Social Sciences Citation Index – 2021</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Implementation science : IS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McGinty, Emma E.</au><au>Tormohlen, Kayla N.</au><au>Barry, Colleen L.</au><au>Bicket, Mark C.</au><au>Rutkow, Lainie</au><au>Stuart, Elizabeth A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes</atitle><jtitle>Implementation science : IS</jtitle><stitle>IMPLEMENT SCI</stitle><addtitle>Implement Sci</addtitle><date>2021-01-07</date><risdate>2021</risdate><volume>16</volume><issue>1</issue><spage>2</spage><epage>13</epage><pages>2-13</pages><artnum>2</artnum><issn>1748-5908</issn><eissn>1748-5908</eissn><abstract>BackgroundThirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition. However, clinical guidelines do not recommend cannabis for treatment of chronic non-cancer pain due to limited and mixed evidence of effectiveness. How state medical cannabis laws affect delivery of evidence-based treatment for chronic non-cancer pain is unclear. These laws could lead to substitution of cannabis in place of clinical guideline-discordant opioid prescribing, reducing risk of opioid use disorder and overdose. Conversely, state medical cannabis laws could lead to substitution of cannabis in place of guideline-concordant treatments such as topical analgesics or physical therapy. This protocol describes a mixed-methods study examining the implementation and effects of state medical cannabis laws on treatment of chronic non-cancer pain. A key contribution of the study is the examination of how variation in state medical cannabis laws' policy implementation rules affects receipt of chronic non-cancer pain treatments.MethodsThe study uses a concurrent-embedded design. The primary quantitative component of the study employs a difference-in-differences design using a policy trial emulation approach. Quantitative analyses will evaluate state medical cannabis laws' effects on treatment for chronic non-cancer pain as well as on receipt of treatment for opioid use disorder, opioid overdose, cannabis use disorder, and cannabis poisoning among people with chronic non-cancer pain. Secondary qualitative and survey methods will be used to characterize implementation of state medical cannabis laws through interviews with state leaders and representative surveys of physicians who treat, and patients who experience, chronic non-cancer pain in states with medical cannabis laws.DiscussionThis study will examine the effects of medical cannabis laws on patients' receipt of guideline-concordant non-opioid, non-cannabis treatments for chronic non-cancer pain and generate new evidence on the effects of state medical cannabis laws on adverse opioid outcomes. Results will inform the dynamic policy environment in which numerous states consider, enact, and/or amend medical cannabis laws each year.</abstract><cop>LONDON</cop><pub>Springer Nature</pub><pmid>33413454</pmid><doi>10.1186/s13012-020-01071-2</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-9042-8611</orcidid><orcidid>https://orcid.org/0000-0001-9406-5953</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1748-5908 |
| ispartof | Implementation science : IS, 2021-01, Vol.16 (1), p.2-13, Article 2 |
| issn | 1748-5908 1748-5908 |
| language | eng |
| recordid | cdi_proquest_journals_2478689623 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; SpringerNature Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Analgesics, Opioid Arthritis Cancer therapies Cannabis Care and treatment Chronic pain Chronic Pain - drug therapy Data collection Econometrics Health Care Sciences & Services Health Policy & Services Humans Law Laws, regulations and rules Life Sciences & Biomedicine Medical marijuana Medical Marijuana - therapeutic use Mixed methods research Mixed-methods Narcotics Pain Pain management Patients Poisoning Policy implementation Population Practice Patterns, Physicians Public policy Science & Technology Study Protocol |
| title | Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T11%3A41%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protocol:%20mixed-methods%20study%20of%20how%20implementation%20of%20US%20state%20medical%20cannabis%20laws%20affects%20treatment%20of%20chronic%20non-cancer%20pain%20and%20adverse%20opioid%20outcomes&rft.jtitle=Implementation%20science%20:%20IS&rft.au=McGinty,%20Emma%20E.&rft.date=2021-01-07&rft.volume=16&rft.issue=1&rft.spage=2&rft.epage=13&rft.pages=2-13&rft.artnum=2&rft.issn=1748-5908&rft.eissn=1748-5908&rft_id=info:doi/10.1186/s13012-020-01071-2&rft_dat=%3Cgale_proqu%3EA650597091%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2478689623&rft_id=info:pmid/33413454&rft_galeid=A650597091&rft_doaj_id=oai_doaj_org_article_73457d08ba1b4152b06b6a1a7f6c69f2&rfr_iscdi=true |